A Study of Acceptance and Commitment Therapy in Patients with Myeloproliferative Neoplasms

Overview

About this study

The purpose of this study is to investigate interest of Acceptance and Commitment Therapy (ACT) delivered in person and on an individual basis in patients with a myeloproliferative neoplasm (MPN).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥ 18 years
Myeloproliferative neoplasm

Exclusion Criteria:

Patients who have started an anti-depressant or anti-anxiety medication for mood disorder symptoms in the past 4 weeks
Patients who are actively undergoing psychological intervention that started in the past 4 weeks
Pregnant patients
Severe Anxiety – Defined as a score of = or >15 the brief GAD
Severe Depression – Defined as score = or > 15 on the PHQ-8

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Leslie Padrnos, M.D.	Closed for enrollment	Contact information: Catherine Margosian C.C.R.C. (480) 342-1938 Margosian.Catherine@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Leslie Padrnos, M.D.

Closed for enrollment

Contact information:

Catherine Margosian C.C.R.C.

(480) 342-1938

Margosian.Catherine@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials